Literature DB >> 18400193

Cancer immunosurveillance: NKG2D breaks cover.

Hans-Gustaf Ljunggren1.   

Abstract

The idea of cancer immunosurveillance has regained interest in recent years. In this issue of Immunity, Guerra et al. (2008) present the first genetic evidence for surveillance of primary tumors by a natural killer cell-associated receptor.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18400193     DOI： 10.1016/j.immuni.2008.03.007

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  9 in total

1.  Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.

Authors:  Ka Yin Kwong; Sivasubramanian Baskar; Hua Zhang; Crystal L Mackall; Christoph Rader
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

2.  NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d.

Authors:  Carlotta Kuylenstierna; Niklas K Björkström; Sofia K Andersson; Peter Sahlström; Lidija Bosnjak; Dominic Paquin-Proulx; Karl-Johan Malmberg; Hans-Gustaf Ljunggren; Markus Moll; Johan K Sandberg
Journal:  Eur J Immunol       Date:  2011-06-06       Impact factor: 5.532

3.  Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.

Authors:  Yenan T Bryceson; Hans-Gustaf Ljunggren; Eric O Long
Journal:  Blood       Date:  2009-07-23       Impact factor: 22.113

4.  Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer.

Authors:  Yajuan Shen; Chao Lu; Wenjun Tian; Laicheng Wang; Bin Cui; Yulian Jiao; Chunyan Ma; Ying Ju; Ling Zhu; Chunhong Shao; Xinqi Liu; Jian Wang; Bingchang Zhang; Zhiming Lu
Journal:  Int J Oncol       Date:  2011-12-22       Impact factor: 5.650

5.  Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity.

Authors:  D Min; X-b Lv; X Wang; B Zhang; W Meng; F Yu; H Hu
Journal:  Br J Cancer       Date:  2013-07-02       Impact factor: 7.640

6.  CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors.

Authors:  Jiemiao Hu; Shiguo Zhu; Xueqing Xia; Liangfang Zhang; Eugenie S Kleinerman; Shulin Li
Journal:  Mol Cancer       Date:  2014-02-24       Impact factor: 27.401

7.  Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion.

Authors:  Marie Lundholm; Mona Schröder; Olga Nagaeva; Vladimir Baranov; Anders Widmark; Lucia Mincheva-Nilsson; Pernilla Wikström
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

8.  KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer.

Authors:  Aifang Jiang; Guanqi Gao; Yanan Zhang; Zeyang Chen
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.379

9.  Metastamir-mediated immune evasion: miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition by NKG2D receptor.

Authors:  Pinchas Tsukerman; Jonatan Enk; Ofer Mandelboim
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.